Walleye Capital LLC
- SEC CIK
- 0001758720
- Latest filing
- Aug 3, 2026
URGN holding history
UroGen Pharma Ltd. in every 13F filed by Walleye Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
URGN overviewAll 13F holders of URGNFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −190,452−100.0% | Sold out | Holders |
| Q3 2025 | 190,452 | $3.80M | <0.1% | −155,710−45.0% | Reduced | Holders |
| Q2 2025 | 346,162 | $4.74M | <0.1% | +346,162 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −57,610−100.0% | Sold out | Holders |
| Q2 2024 | 57,610 | $966.7K | <0.1% | +57,610 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −27,218−100.0% | Sold out | Holders |
| Q4 2023 | 27,218 | $408.3K | <0.1% | +27,218 | New | Holders |